There is 1 paper on dual-organ steatosis in aging research: 1 observational study in people.
1 paper studies it2 findings
See all 1 papers on dual-organ steatosis
“the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219-3.322, p = 0.006).”
- Humans1
Associations
2Ventricular function
downin humans1
1 study
Ventricular function
downin humans1
Dual-organ steatosis is associated with ventricular function in humans.
“Dual-organ steatosis was also associated with marked cardiac alterations, specifically increased left ventricular mass and impaired ventricular function.”
HumansCoexisting metabolic dysfunction-associated steatotic liver disease and pancreatic steatosisheartn = 16,408
Liver-Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction
Liver international : official journal of the International Association for the Study of the Liver
Cardiometabolic multimorbidity
upin humans1HR 2.013
1 study
Cardiometabolic multimorbidity
upin humans1HR 2.013
Dual-organ steatosis is associated with cardiometabolic multimorbidity in humans (HR 2.013, 95% CI 1.219–3.322; p = 0.006).
“the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219-3.322, p = 0.006).”
HumansCoexisting metabolic dysfunction-associated steatotic liver disease and pancreatic steatosisMedian follow-up of 5.6 yearsn = 16,408
Liver-Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction
Liver international : official journal of the International Association for the Study of the Liver